Psoralidin exerts anti-tumor, anti-angiogenic, and immunostimulatory activities in 4T1 tumor-bearing balb/c mice

CONCLUSIONS: Psoralidin shows the anti-cancer potential in an animal model of breast cancer; however, further studies are recommended to elucidate its mechanisms of action.PMID:34496167 | DOI:10.1515/hmbci-2021-0028

Source: Clinical Breast Cancer - September 8, 2021 Category: Cancer & Oncology Authors: Davar Amani Elham Shakiba Ehsan Motaghi Hiva Alipanah Mahshad Jalalpourroodsari Mohsen Rashidi Source Type: research